Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
9.25
+0.40 (4.52%)
Nov 6, 2026, 4:00 PM EST - Market closed
Q32 Bio Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Q32 Bio stock has a consensus rating of "Strong Buy" and an average price target of $39.67. The average 1-year stock price forecast is 328.86% higher than the current stock price, while the lowest is $29 (+213.51%) and the highest is $59 (+537.84%).
Price Target: $39.67 (+328.86%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Q32 Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 4 | 5 | 5 | 5 | 6 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 5 | 5 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $40 | Buy | Reiterates | $40 | +332.43% | Nov 5, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $34 | Buy | Reiterates | $34 | +267.57% | Nov 5, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 | Buy | Maintains | $40 | +332.43% | Nov 5, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $59 | Buy | Maintains | $59 | +537.84% | Nov 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $36 | Buy | Reiterates | $36 | +289.19% | Nov 4, 2026 |
Financial Forecast
Revenue This Year
333.33K
from 53.74M
Decreased by -99.38%
Revenue Next Year
833.33K
from 333.33K
Increased by 150.00%
EPS This Year
-1.13
EPS Next Year
-1.02
from -1.13
EPS and Forward PE are based on non-GAAP adjusted numbers.